WO2009071096A3 - Combination of medical and physical cooling treatment of ischemic effects - Google Patents
Combination of medical and physical cooling treatment of ischemic effects Download PDFInfo
- Publication number
- WO2009071096A3 WO2009071096A3 PCT/DK2008/050294 DK2008050294W WO2009071096A3 WO 2009071096 A3 WO2009071096 A3 WO 2009071096A3 DK 2008050294 W DK2008050294 W DK 2008050294W WO 2009071096 A3 WO2009071096 A3 WO 2009071096A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- combination
- agonists
- hypothermia
- receptor agonists
- medical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
The present invention relates to the induction of hypothermia in humans in a predictable and dose responsive fashion by use of combination of physical /mechanical hypothermia therapy and a pharmaceutical composition comprising at least one compound selected among a (1) vanilloid receptor agonists, capsaicinoids or capsaicinoid-like agonists reaching and binding to vanilloid receptors, and (2) cannabinoids or cannabimimetic agonists reaching and binding to cannabinoid receptors, and (3) adenosine receptor agonists, and (4) neurotensin receptor agonists, and (5) thyroxine derivatives, and (6) cytochrome c oxidase inhibitors and (7) oxygen tension reducers thereby inducing hypothermia, thus benefiting patients suffering from illnesses characterized by tissue anoxia.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200701742 | 2007-12-05 | ||
DKPA200701744 | 2007-12-05 | ||
DKPA200701742 | 2007-12-05 | ||
DKPA200701744 | 2007-12-05 | ||
DKPA200801105 | 2008-08-15 | ||
DKPA200801104 | 2008-08-15 | ||
DKPA200801104 | 2008-08-15 | ||
DKPA200801105 | 2008-08-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009071096A2 WO2009071096A2 (en) | 2009-06-11 |
WO2009071096A3 true WO2009071096A3 (en) | 2010-01-07 |
Family
ID=40679505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK2008/050294 WO2009071096A2 (en) | 2007-12-05 | 2008-12-05 | Combination of medical and physical cooling treatment of ischemic effects |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009071096A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2155300A1 (en) | 2007-04-05 | 2010-02-24 | Velomedix, Inc | Automated therapy system and method |
EP2167000A1 (en) | 2007-07-09 | 2010-03-31 | Velomedix, Inc | Hypothermia devices and methods |
WO2012006625A2 (en) | 2010-07-09 | 2012-01-12 | Velomedix, Inc. | Method and apparatus for pressure measurement |
GB2504263B (en) * | 2012-06-08 | 2015-09-16 | Gw Pharma Ltd | Synergistic therapies for neuroprotection |
DK3466930T3 (en) | 2013-02-08 | 2022-09-05 | Gen Mills Inc | FOOD PRODUCT WITH REDUCED SODIUM CONTENT |
US10092591B2 (en) | 2014-02-27 | 2018-10-09 | University Of Alaska Fairbanks | Methods and compositions for the treatment of ischemic injury to tissue using therapeutic hypothermia |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040102368A1 (en) * | 2002-11-27 | 2004-05-27 | Katz Laurence M. | Methods of treating cerebral ischemia |
WO2007140786A1 (en) * | 2006-06-08 | 2007-12-13 | Neurokey A/S | Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia |
WO2008040360A2 (en) * | 2006-10-04 | 2008-04-10 | Neurokey A/S | Use of hypothermia inducing drugs to treat ischemia |
-
2008
- 2008-12-05 WO PCT/DK2008/050294 patent/WO2009071096A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040102368A1 (en) * | 2002-11-27 | 2004-05-27 | Katz Laurence M. | Methods of treating cerebral ischemia |
WO2007140786A1 (en) * | 2006-06-08 | 2007-12-13 | Neurokey A/S | Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia |
WO2008040360A2 (en) * | 2006-10-04 | 2008-04-10 | Neurokey A/S | Use of hypothermia inducing drugs to treat ischemia |
Non-Patent Citations (9)
Title |
---|
APPENDINO G ET AL: "TRPV1 (vanilloid receptor, capsaicin receptor) agonists and antagonists", EXPERT OPINION ON THERAPEUTIC PATENTS, INFORMA HEALTHCARE, GB, vol. 13, no. 12, 1 December 2003 (2003-12-01), pages 1825 - 1837, XP002487646, ISSN: 1354-3776 * |
BONFILS P K ET AL: "Estimation of the hypothermic component in neuroprotection provided by cannabinoids following cerebral ischemia", NEUROCHEMISTRY INTERNATIONAL, PERGAMON PRESS, OXFORD, GB, vol. 49, no. 5, 1 October 2006 (2006-10-01), pages 508 - 518, XP025067906, ISSN: 0197-0186, [retrieved on 20061001] * |
DING ET AL: "Capsaicin evokes hypothermia independent of cannabinoid CB1 and CB2 receptors", BRAIN RESEARCH, ELSEVIER, AMSTERDAM, NL, vol. 1065, no. 1-2, 14 December 2005 (2005-12-14), pages 147 - 151, XP005206563, ISSN: 0006-8993 * |
HAYAKAWA KAZUHIDE ET AL: "Delta(9)-tetrahydrocannabinol (Delta(9)-THC) Prevents cerebral infarction via hypothalamic-independent hypothermia", LIFE SCIENCES, vol. 80, no. 16, March 2007 (2007-03-01), pages 1466 - 1471, XP002551820, ISSN: 0024-3205 * |
LEKER RONEN R ET AL: "Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210", STROKE, LIPPINCOTT WILLIAMS & WILKINS, US, vol. 34, no. 8, 1 August 2003 (2003-08-01), pages 2000 - 2006, XP002451424, ISSN: 0039-2499 * |
MAULER FRANK ET AL: "BAY 38-7271: a novel highly selective and highly potent cannabinoid receptor agonist for the treatment of traumatic brain injury", CNS DRUG REVIEWS, BRANFORD, CT, US, vol. 9, no. 4, 1 January 2003 (2003-01-01), pages 343 - 358, XP002451422, ISSN: 1080-563X * |
OLSEN T S ET AL: "Therapeutic hypothermia for acute stroke", LANCET NEUROLOGY, LANCET PUBLISHING GROUP, LONDON, GB, vol. 2, no. 7, 1 July 2003 (2003-07-01), pages 410 - 416, XP004810147, ISSN: 1474-4422 * |
PEGORINI S ET AL: "Capsaicin exhibits neuroprotective effects in a model of transient global cerebral ischemia in Mongolian gerbils", BRITISH JOURNAL OF PHARMACOLOGY, NATURE PUBLISHING GROUP, BASINGSTOKE, HANTS, vol. 144, 1 January 2005 (2005-01-01), pages 727 - 735, XP007904383, ISSN: 0007-1188 * |
RAWLS S M ET AL: "CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalen yl-carbonyl) -6H-pyrrolo[3,2,1 ij]quinolin-6-one]-induced hypothermia", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, US, vol. 301, no. 3, 1 January 2002 (2002-01-01), pages 963 - 968, XP002451426, ISSN: 0022-3565 * |
Also Published As
Publication number | Publication date |
---|---|
WO2009071096A2 (en) | 2009-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008040361A3 (en) | Use of a combination of hypothermia inducing drugs | |
WO2008040360A3 (en) | Use of hypothermia inducing drugs to treat ischemia | |
WO2010015260A3 (en) | Administration by infusion for the treatment of ischemic effects | |
WO2009124552A3 (en) | Use of a combination of hypothermia inducing drugs | |
WO2009071096A3 (en) | Combination of medical and physical cooling treatment of ischemic effects | |
EA200800056A1 (en) | CANNABINOID ACTIVE PHARMACEUTICAL INGREDIENT FOR MEDICINAL FORMS | |
NO20072461L (en) | Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity | |
DE60331236D1 (en) | ORAL COMPOSITIONS FOR THE TREATMENT OF DIABETES | |
BRPI0519803A2 (en) | methods for purifying trans - (-) - delta9-tetrahydrocannabinol and trans - (+) - delta9-tetrahydrocannabinol | |
MX358617B (en) | Dpp iv inhibitor formulations. | |
WO2009071094A3 (en) | Combination treatment of ischemic effects | |
MX2009011900A (en) | Diabetic wound healing. | |
IL168308A (en) | Compositions containing roflumilast and formoterol | |
ZA200904704B (en) | Treatment of cachexia | |
CO5690571A2 (en) | SYNERGIC COMBINATION INCLUDING ROFLUMILAS AND (R, R) -FORMOTEROL | |
IS8373A (en) | Use of oxcarbazepine to treat diabetes due to diabetes mellitus and to improve sleep | |
WO2009124551A3 (en) | Use of vanilloid receptor agonists as hypothermia inducing drugs for the treatment of ischemia | |
EA201000739A1 (en) | NEW MEDICAL APPLICATION OF SALTS 3- (2,2,2-TRIMETHYL HYDRAZINIUM) PROPIONATE | |
NO20062369L (en) | Use of a pyrazole derivative for the manufacture of medications to prevent and treat dyslipidemia and diseases associated with dyslipidemia and / or obesity | |
BR0214776A (en) | Combination of a selective pde4 inhibitor and a beta-2 adrenergic receptor agonist | |
PT1490049E (en) | CITALOPRAM FOR THE TREATMENT OF THE HIGH SANGUINIA PREVENTION. | |
IS6976A (en) | Combined dose of cyclooxygenase (COX) inhibitor, vitamin D3 including analogues and metabolites and / or calcium to prevent epithelial cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08856983 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 14.09.2010) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08856983 Country of ref document: EP Kind code of ref document: A2 |